Latest filing published 03 Feb 2021 for Lumos Pharma, INC..
Insider track record
Eugene P. Kennedy: trading record in brief
Eugene P. Kennedy is a declared insider of Lumos Pharma, Inc., with filings sourced from SEC (Form 4). In total, 7 filings cover trades dated from 4 January 2018 to 1 February 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 3 February 2021, reports a share grant in Lumos Pharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eugene P. Kennedy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 939 shares0Common StockSEC:0001126234-21-000008:0
- 9,000 shares0Common StockSEC:0001126234-20-000045:0
- 376 shares@ US$2.2142.5% of flowCommon StockSEC:0001126234-20-000006:0
- 359 shares@ US$1.5728.3% of flowCommon StockSEC:0001126234-19-000073:0
- 376 shares@ US$1.558.9% of flowCommon StockSEC:0001126234-19-000008:0
- 85 shares@ US$8.6210.4% of flowCommon StockSEC:0001126234-18-000018:0
- 409 shares@ US$10.0659.3% of flowCommon StockSEC:0001126234-18-000014:0
7 of 7 declarations